2024年7月9日 · Common Generic Name(s): dabigatran, dabigatran etexilate mesylate; Pronunciation: DA-bi-GAT-ran , pra-dax-a; Drug Classes: anticoagulant, thrombin inhibitor

2023年6月12日 · Dabigatran is used to treat blood clots deep in the body (deep vein thrombosis, DVT) and lungs (pulmonary embolism, PE) in adults who have received blood thinners by injection for 5 to 10 days.

2024年3月7日 · Easy-to-read patient leaflet for Dabigatran Etexilate. Includes indications, proper use, special instructions, precautions, and possible side effects. Skip to main content

2024年2月22日 · Pradaxa (dabigatran) is an anticoagulant that works by blocking the clotting protein thrombin. Pradaxa is used to prevent blood clots from forming because of a certain irregular heart rhythm (atrial fibrillation). Preventing these blood clots helps to reduce the risk of a stroke. What Are Side Effects of Pradaxa?

PRADAXA is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. For patients with creatinine clearance (CrCl) >30 mL/min, the...

2023年8月22日 · Dabigatran works by preventing blood clots from forming in the body. Pradaxa is used to treat blood clots deep in the body (deep vein thrombosis, DVT) and lungs (pulmonary embolism, PE) in adults who have received blood thinners by injection for 5 to 10 days.

Addition of ethyl ester and hexyloxycarbonyl carbamide hydrophobic side chains led to the orally absorbed prodrug, BIBR 1048 (dabigatran etexilate). [ 39 ] In March 2008, the European Medicines Agency (EMA) granted marketing authorization for Pradaxa for the prevention of thromboembolic disease following hip or knee replacement surgery and for ...

2010年11月23日 · PRADAXA® (dabigatran etexilate mesylate) capsules for ... PRADAXA is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

2024年10月3日 · Dabigatran etexilate mesylate is a yellow-white to yellow color powder. Sparingly soluble in methanol. Dabigatran etexilate capsules are supplied in 75 mg, 110 mg and 150 mg strengths for oral administration.

2023年11月27日 · PRADAXA Oral Pellets contain dabigatran etexilate mesylate, a direct thrombin inhibitor. The chemical name of dabigatran etexilate mesylate is β-Alanine ... 12.1 Mechanism of Action - Dabigatran and its acyl glucuronides are competitive, direct thrombin inhibitors.